It belongs to the same class of medications (GLP-1 RAs) and is used for the treatment of Type 2 Diabetes mellitus as well as weight loss
Sudden confusion, severe headache, difficulty speaking, weakness, vision changes, or altered consciousness may indicate serious conditions such as stroke, severe hypoglycemia, or other neurological emergencies
PMID 38446869
However, just because the body has precursors to a final product does not mean that it can or will be made
A 2019 study published in Nature Medicine examined Akkermansia supplementation in overweight and obese insulin-resistant volunteers
The simplest way to picture it: GLP-1 tells your gut to slow down, while amylin tells your brain you have had enough food - through a different channel